Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 May 4;7(5):e875. doi: 10.1097/HS9.0000000000000875

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.

This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

PMC Copyright notice

Figure 1. — Outcome of patients with high hyperdiploid acute lymphoblastic leukemia. (A) Kaplan-Meier of event-free survival including both MRD-guided and non-MRD-guided trials. (B) Kaplan-Meier of event-free survival of MRD-guided trials. (C) Effect of IKZF1 deletions on hazard ratio of event-free survival: pooled data from MRD-guided and non-MRD-guided trials. (D) Effect of IKZF1 deletions on hazard ratio of event-free survival: data from each MRD-guided trial. P-values from log-rank test for comparing survival function estimates. MRD = minimal residual disease.